Tetracera potatoria
Tetracera potatoria · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Tetracera potatoria is a botanical species recognized for its significant therapeutic potential in pharmacological studies. Recent research has focused on the antimicrobial activities exhibited by its medicinal components. Specifically, medium polar extracts derived from the plant's leaves and stems have demonstrated efficacy against various pathogens. These extracts show promising results in combating Leishmania infantum and addressing various respiratory infections. Consequently, this plant represents a valuable subject for developing new treatments against these challenging biological conditions.
- Synonyms
- Tetracera Stuhlmanniana Var. Occidentalis · Tetracera Obtusata
- Common names
- Not available
- Family
- Dilleniaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Stem
Classification
Synonyms
Tetracera potatoria is a botanical species that is recognized through several different taxonomic designations. In various scientific records, it is identified by the synonym Tetracera obtusata. Furthermore, the plant is also associated with the name Tetracera stuhlmanniana var. occidentalis. These overlapping nomenclatures highlight the complex botanical relationships inherent in classifying such species. Understanding these synonyms is essential for researchers seeking to maintain accuracy in plant identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Tetracera potatoria is a fascinating member of the kingdom Plantae. This plant is classified under the class Equisetopsida, which defines its fundamental biological structure. Within this framework, it belongs to the order Dilleniales. It is further categorized into the family Dilleniaceae, showcasing its specific evolutionary connections. Finally, its taxonomic identity is solidified by its placement within the genus Tetracera.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Dilleniales |
| Family | Dilleniaceae |
| Genus | Tetracera |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Tetracera potatoria is a plant species with a broad and diverse distribution across the African continent. In East Tropical Africa, it is commonly found within the borders of Kenya, Tanzania, and Uganda. Its presence also extends into Northeast Tropical Africa, specifically covering the regions of Sudan and South Sudan. Furthermore, the species can be located in West Tropical Africa, with documented occurrences in Benin. This widespread range highlights the adaptability of the plant across various tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Tetracera potatoria is characterized by its distinct shrub-like growth form. This species possesses an obligatory climbing habit, relying on surrounding structures for support as it ascends. While it typically maintains a modest stature, its height can vary significantly depending on environmental conditions. Ultimately, the plant can reach a maximum height of approximately 9.14 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Tetracera potatoria is a species of interest within the context of medicinal plant research conducted in Guinea. This study focused on evaluating the antimicrobial potential of various ethnobotanically selected plants used to treat infectious diseases. By interviewing traditional healers and herbalists, researchers were able to identify species with significant therapeutic applications. The investigation specifically looked for activities against pathogens such as bacteria, fungi, and parasites. Ultimately, these findings highlight the importance of such plants in the potential development of new antifungal or antimalarial agents.
Compounds
Tetracera potatoria is a medicinal plant traditionally utilized in Africa for treating respiratory infections and tuberculosis-related ailments. Recent scientific investigations into its stem bark have successfully isolated several significant secondary metabolites. Among these identified compounds are the triterpenoids betulin and lupeol. Furthermore, the plant was found to contain betulinic acid, which demonstrates appreciable anti-mycobacterial activity against specific strains. These chemical relationships highlight the plant's potential as a valuable source for developing novel anti-tuberculosis drugs.
Conditions
Tetracera potatoria serves as a traditional medicinal plant used to treat various respiratory infections and tuberculosis-related ailments. This plant has demonstrated effectiveness in inhibiting Morexella cattarhalis, a pathogen associated with respiratory tract issues. Research into its antimicrobial potential further suggests its ability to treat Leishmania infantum. Additionally, the species is recognized for its capacity to treat C. albicans. These diverse therapeutic properties validate its significant role in African traditional medicine.
Preparations
Tetracera potatoria is prepared as medium polar extracts using a mixture of MeOH/DCM in a 1:1 ratio. These specific extracts were derived from the plant parts as part of a study investigating traditional medicinal uses by the Bakola pygmies. The prepared medium polar extracts were then assayed against various pathogens, including those associated with respiratory tract ailments. In the testing process, Tetracera potatoria demonstrated effectiveness in inhibiting Morexella cattarhalis. This preparation method allowed researchers to evaluate the plant's antimicrobial efficacy and its potential for treating tuberculosis-related symptoms.
Parts used
Tetracera potatoria is a medicinal plant traditionally utilized in Africa to treat respiratory infections and tuberculosis-related ailments. Scientific investigations into this species have focused on the bioactive potential found within its various anatomical structures. Specifically, the leaves of the plant have demonstrated antibacterial activity against certain Mycobacterium strains. Furthermore, researchers have successfully isolated several secondary metabolites from the stem bark to study their therapeutic properties. These findings regarding the leaf and stem components support the continued medicinal use of the species in traditional healing practices.